Stocktoria
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $160.0M | $154.0M | $200.5M | $128.3M | $130.5M | $78.9M | $90.9M | $78.6M | $93.5M | $90.7M |
| Gross profit | $45.8M | $37.3M | $52.8M | $49.0M | $58.9M | $32.6M | $34.6M | $25.1M | $34.7M | $44.2M |
| R&D expense | $97.3M | $134.9M | $187.2M | $193.0M | $112.9M | $64.2M | $59.6M | $62.6M | $65.3M | $67.6M |
| SG&A expense | $141.5M | $175.0M | $169.8M | $160.9M | $124.1M | $72.8M | $75.5M | $63.5M | $59.1M | $47.8M |
| Operating income | -$553.9M | -$474.3M | -$334.5M | -$307.2M | -$210.4M | -$104.4M | -$100.5M | -$101.0M | -$89.8M | -$71.2M |
| Interest expense | — | — | $14.3M | $14.7M | $12.5M | $267,000 | $2.6M | $2.4M | $2.9M | $3.2M |
| Income tax | $318,000 | $316,000 | -$11.4M | $0 | -$93.6M | — | — | — | — | — |
| Net income | -$546.4M | -$309.9M | -$306.7M | -$314.2M | -$181.2M | $29.4M | -$84.1M | -$102.6M | -$92.2M | -$74.4M |
| EPS (diluted) | $-1.82 | $-1.59 | $-1.21 | $-1.40 | $-0.89 | $0.17 | $-0.55 | $-0.76 | — | — |
| Operating cash flow | -$111.2M | -$206.1M | -$259.2M | -$263.2M | -$111.2M | $19.5M | -$78.3M | -$66.4M | -$67.5M | -$67.9M |
| Free cash flow | -$113.9M | -$212.2M | -$268.0M | -$280.0M | -$117.1M | $18.5M | -$81.1M | -$68.3M | -$78.0M | -$76.1M |
| Cash & equivalents | $63.7M | $55.4M | $179.9M | $325.1M | $460.7M | $81.6M | $29.6M | $18.8M | $16.5M | $16.8M |
| Inventory | $49.3M | $58.8M | $56.7M | $50.4M | $24.6M | $14.2M | $13.3M | $17.9M | $23.1M | $15.6M |
| Total assets | $784.1M | $1.3B | $1.7B | $1.8B | $2.0B | $414.0M | $148.0M | $170.3M | $144.1M | $137.9M |
| Total liabilities | $778.7M | $753.9M | $1.0B | $1.2B | $1.2B | $78.5M | $93.1M | $56.2M | $58.0M | $53.2M |
| Shareholders' equity | $5.3M | $506.6M | $701.3M | $562.9M | $791.0M | $335.5M | $54.9M | $114.1M | $86.1M | $84.7M |
Growth · year-over-year · Revenue CAGR 6.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +3.9% | -23.2% | +56.3% | -1.7% | +65.4% | -13.2% | +15.6% | -15.9% | +3.0% | -2.2% |
| Net income growth | — | — | — | — | -716.3% | — | — | — | — | — |
| EPS growth | — | — | — | — | -623.5% | — | — | — | — | — |
| Free cash flow growth | — | — | — | — | -734.3% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.